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CASE REPORT 
An 83-year-old female patient was admitted to our de-
partment for investigation of extensive painless lesions on the 
lower abdomen. Additionally, she complained of asthenia, 
anorexia and a weight loss of 10 kg in 6 months. Her pre-
vious medical history was only positive for arterial hyperten-
sion under treatment with nifedipine.
Physical examination revealed multiple asymptomatic, firm, 
erythematous confluent nodules and tumors on the suprapubic 
area (Fig. 1A), as well as enlarged, bilateral painless inguinal 
lymph nodes. Moreover, numerous erythematous patches and 
plaques were observed on the lower back (Fig. 1B) and an in-
durated subcutaneous tumor was palpable on the lumbosacral 
region. The remaining examination was unremarkable.
Laboratory evaluation revealed normal complete blood 
counts, but elevated lactate dehydrogenase (438 U/L; 
N<225) and beta-2 microglobulin levels (4550 μg/L; 
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Figure 1 - (A) Several firm, erythematous confluent nodules and tumors on the suprapubic area. (B) Numerous erythematous patches and plaques 
on the dorsolumbar region.
A B
174
Qual o Seu Diagnóstico?
Revista SPDV 78(2) 2020; Nódulos eritematosos suprapúbicos numa idosa; Mariana Esteves, Júlia Vide, Filomena Azevedo.
N<2350). A full body computed tomography scan identified 
numerous inguinal, pelvic and retroperitoneal lymphadeno-
pathies, along with a large subcutaneous mass involving the 
skin and the adjacent left lumbar and gluteal muscles (Fig. 2).
Histopathological examination of a skin biopsy showed 
a dense and diffuse infiltrate extending into the deep dermis 
and sparing its upper portion (Fig. 3A). The infiltrate was 
comprised of sheets of intermediate to large-sized cells with 
centroblastic and immunoblastic morphology, displaying 
frequent mitotic figures and apoptotic bodies (Fig. 3B). 
Neoplastic cells stained positive for CD20, BCL-2, MUM-1, 
BCL-6 (Fig. 4) and the Ki-67 proliferation index was 75%. 
An inguinal lymph node fine-needle biopsy was also perfor-
med, which showed infiltration of intermediate to large-si-
zed, irregular lymphoid cells expressing surface CD10 and 
IgG kappa. Given the skin biopsy result, both bone marrow 
and excisional lymph node biopsies were not performed.
Figure 2 - Computed tomography scan showing a large subcuta-
neous mass of 17x21x7, 5cm, involving the skin and the adjacent left 
lumbar and gluteal muscles. 
Figure 3 - (A) Dense and diffuse infiltrate extending into the deep dermis and sparing its upper portion (“grenz zone pattern”) (H&E, 40x). (B) Sheets 
of intermediate to large-sized cells with centroblastic and immunoblastic morphology, along with frequent mitotic figures and apoptotic bodies (H&E, 
400x).
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Figure 4 - Immunohistochemical analysis disclosed positivity of neoplastic cells for CD20 (A), BCL-2 (B), MUM-1 (C) and BCL-6 (D).
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WHAT IS YOUR DIAGNOSIS? 
DIFFUSE LARGE B-CELL LYMPHOMA 
Combination of clinical, radiological and histopatholo-
gical findings led to a diagnosis of systemic diffuse large 
B-cell lymphoma (DLBCL) with cutaneous infiltration. The 
patient was started on chemotherapy with rituximab 360 
mg/m2 and bendamustine 90 mg/m2, of which she com-
pleted two cycles. Despite an initial clinical improvement, 
disease progression eventually occurred and she died 3 
months after the diagnosis.
Cutaneous lymphoma can be divided into two catego-
ries: primary cutaneous lymphoma (PCL), which is confined 
to the skin without evidence of extracutaneous involvement 
at the time of presentation, and secondary cutaneous lym-
phoma (SCL), in which skin lesions develop concurrently or 
after a diagnosis of systemic lymphoma.1 While PCL has 
been analyzed in a few large-scale epidemiological studies, 
the same is not true for SCL. Consequently, its incidence, 
clinical features and survival outcomes remain poorly un-
derstood.1-3
In the published literature, mature T-cell and NK-cell 
lymphomas comprise more than half of SCL, while B-cell 
lineage neoplasms represent about 40% of cases.1-4 In PCL, 
this proportion is much more pronounced, given the con-
tribution of mycosis fungoides and CD30+ T-cell lympho-
proliferative disorders. DLBCL is the most frequent subtype 
of non-Hodgkin lymphoma and accounts for up to 35% of 
cases of secondary lesions in some series.1,2,4
When comparing primary and secondary cutaneous 
DLBCL, no significant differences are found regarding num-
ber, morphology or location of skin lesions.5,6 Nevertheless, 
cutaneous dissemination, as in our case, is more common in 
secondary DLBCL and portends a worse prognosis.2,5,6
Overall survival rates vary considerably between patients 
with DLBCL, given the distinct clinical presentation and res-
ponse to treatment. Not surprisingly, extranodal involvement 
in the setting of systemic lymphoma denotes disease pro-
gression and is associated with a poorer outcome.2,5 Addi-
tional factors of prognostic relevance in secondary B-cell 
lineage lymphoma include elevated serum lactate dehydro-
genase levels at initial staging and early occurrence of skin 
lesions (less than 6 months from the diagnosis of the pri-
mary disease),2,6 both of which were seen in our patient. In 
contrast, conventional prognostic factors for DLBCL, such as 
age, gender or Ann Arbor stage, do not seem to significantly 
influence survival in SCL.2,5
Herein, we report a case of DLBCL presenting with unu-
sually extensive soft-tissue involvement, which predicted a 
more aggressive clinical course. Cutaneous lesions were the 
first manifestation of the systemic disease and therefore re-
presented the key for its diagnosis.
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